INTRAVENOUS IMMUNOGLOBULIN (IVIG) Market Analysis & Technological Innovation by Leading Key Players - Baxter international Inc., CSL Ltd., Grifols, S.A., Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., Shire P

Intravenous Immunoglobulin (IVIG) Market Overview:

Immunoglobulins (IGs), also known as antibodies, are glycoproteins produced by the blood plasma in response to foreign bodies or antigens. They are highly complex entities and are specific in their action. These IGs are obtained from blood through the process of fractionation and are purified for use in therapeutic and non-therapeutic areas. The global intravenous immunoglobulin (IGIV) market was valued at $7,861 million in 2015 and is projected to reach $12,632 million by 2022, registering a CAGR of 7.1% from 2016 to 2022.

Get sample copy of this report: https://www.bigmarketresearch.com/request-sample/2819888?utm_source=Aniket&utm_medium=OPPR

Increase in prevalence of immunodeficiency and autoimmune diseases such as chronic inflammatory demyelinating polyneuropathy, hypogammaglobulinemia & others and rise in adoption of immunoglobulin treatments for the treatment of various autoimmune disorders majorly drive the growth of the IVIG market. Further, the increase in approval of IVIG drugs from the Food and Drug Administration (FDA), European Medicine Agency (EMA), and other government agencies is expected to accelerate the market growth of IVIG industry. However, stringent government regulations, inflated cost of therapy, and high risk of side effects associated with the use of immunoglobulin intravenously are anticipated to hamper the market growth. On the contrary, significant investment in healthcare sector is expected to provide lucrative opportunities for the market growth in the near future.

The global IVIG market is characterized based on application, type, and region. Based on application, the market is segmented into hypogammaglobulinemia, CIDP, immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura (ITP), inflammatory myopathies, specific antibody deficiency, Guillain–Barre syndrome, and others. Based on type, the market is classified into IgG, IgA, IgM, IgE, and IgD. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Intravenous Immunoglobulin (IVIG) Market:
• The report provides an in-depth analysis of the intravenous immunoglobulin market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in this study.
• The report provides a detailed quantitative analysis of the industry from 2016 to 2022 to assist stakeholders to capitalize on the prevailing market opportunities.
• An extensive analysis of the key segments of the industry helps to understand the trends in the intravenous immunoglobulin market globally.
• Key players and their strategies are provided to understand the competitive outlook of the industry.

Intravenous Immunoglobulin (IVIG) Key Market Segments:
By Application
• Hypogammaglobulinemia
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Primary Immunodeficiency Disease
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• Idiopathic Thrombocytopenic Purpura (ITP)
• Inflammatory Myopathies
• Specific Antibody Deficiency
• Guillain–Barre Syndrome
• Others

By Type
• IgG
• IgA
• IgM
• IgE
• IgD

BY REGION
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Russia
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa

Request a Discount this report:@ https://www.bigmarketresearch.com/request-for-discount/2819888?utm_source=Aniket&utm_medium=OPPR

Key Players Profiled
Baxter international Inc., CSL Ltd., Grifols, S.A., Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., Shire Plc.(Baxalta), Bayer AG

The other players of the intravenous immunoglobulin market include (companies not profiled in the report):
• Hualan Biological Engineering Inc.
• Omrix Biopharmaceuticals Ltd.
• Behring GmbH
• Shanghai RAAS Blood Products Co., Ltd.
• Option Care Enterprises, Inc.
• ADMA Biologics, Inc.
• BioScrip, Inc.

Table of Contents :
Chapter: 1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS:
1.3. KEY MARKET SEGMENTS:
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst tools and models
Chapter: 2. EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Report Full Summary @ https://www.bigmarketresearch.com/intravenous-immunoglobulin-IVIG-market

About Us:
Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.
We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact Us:
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
call answer Direct:+1-971-202-1575
call answer Toll Free:+1-800-910-6452
email help@bigmarketresearch.com

This release was published on openPR.